For instance, even though genes PLXNB1, PLXNB3, and PLXND1 showed no significant differential expression in breast cancer tumors compared to normal, their expression was associated either with less aggressive breast cancer subtypes (PLXNB1) or with more aggressive subtypes or had further deregulated expression in metastatic tumors (PLXNB3 and PLXND1). This evidence concerns the gene PLXNB3 and breast cancer.